Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2018 Filed Sep 6, 2018 14:21 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionRestricted Stock Unit · Derivative | 153 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-026852 · form4.xml · derivative · entry 3 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,068 Underlying: Common Stock · 153 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17. F4 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 9/1/17. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 14:21 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Tax withholdingCommon Stock | 69 | $169.15 | $11,671.35 |
DisclosureSEC source: 0001127602-18-026852 · form4.xml · nonDerivative · entry 2 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,849.6159 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 155.2506 shares acquired on June 29, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 14:21 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionCommon Stock | 153 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-026852 · form4.xml · nonDerivative · entry 1 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,918.6159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · balance_after: Amount includes 155.2506 shares acquired on June 29, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:41 UTC |
KING DAVID PDirector · President & CEO
|
GiftCommon Stock | 695 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-025493 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,711.3563 F1 · balance_after: Amount includes 126.0265 shares acquired on June 29, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| August 13, 2018 Filed Aug 15, 2018 21:41 UTC |
KING DAVID PDirector · President & CEO
|
GiftCommon Stock | 1,389 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-025493 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,406.3563 F1 · balance_after: Amount includes 126.0265 shares acquired on June 29, 2018 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:11 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionNon-qualified Stock Options · Derivative | 13,000 | $0.00 Strike: $84.86 | $0.00 |
DisclosureSEC source: 0001127602-18-020440 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,000 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2012 Omnibus Incentive Plan. F3 · derivative.exercise_date: The option vests in three equal annual installments beginning on 5/24/13 and is now fully exercisable. Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:11 UTC |
Dodson Edward TPrincipal Accounting Officer
|
SaleCommon Stock | 13,000 | $183.35 | $2,383,557.80 |
DisclosureSEC source: 0001127602-18-020440 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,112.9891 F1 · price: The price of $183.3506 per share represents a weighted average of sales prices ranging from $182.97 to $183.84 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 15:11 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 13,000 | $84.86 | $1,103,180.00 |
DisclosureSEC source: 0001127602-18-020440 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,112.9891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 18:59 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
SaleCommon Stock | 4,500 | $182.10 | $819,451.35 |
DisclosureSEC source: 0001127602-18-020117 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,754.6826 F1 · price: The price of $182.1003 per share represents a weighted average of sales prices ranging from $182.00 to $182.35 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a securityholder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:17 UTC |
Gilliland Dwight GaryDirector
|
SaleCommon Stock | 400 | $181.30 | $72,520.00 |
DisclosureSEC source: 0001127602-18-019735 · form4.xml · nonDerivative · entry 4 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,501 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:17 UTC |
Gilliland Dwight GaryDirector
|
SaleCommon Stock | 300 | $181.29 | $54,387.00 |
DisclosureSEC source: 0001127602-18-019735 · form4.xml · nonDerivative · entry 3 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,901 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:17 UTC |
Gilliland Dwight GaryDirector
|
SaleCommon Stock | 436 | $181.29 | $79,040.26 |
DisclosureSEC source: 0001127602-18-019735 · form4.xml · nonDerivative · entry 2 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,201 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:17 UTC |
Gilliland Dwight GaryDirector
|
SaleCommon Stock | 127 | $181.26 | $23,020.02 |
DisclosureSEC source: 0001127602-18-019735 · form4.xml · nonDerivative · entry 1 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,637 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:16 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
SaleCommon Stock | 315 | $182.37 | $57,446.55 |
DisclosureSEC source: 0001127602-18-019731 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,940 Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 20:16 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
SaleCommon Stock | 5,185 | $182.30 | $945,225.50 |
DisclosureSEC source: 0001127602-18-019731 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,255 Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 12:15 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
SaleCommon Stock | 1,610 | $182.50 | $293,822.75 |
DisclosureSEC source: 0001127602-18-019468 · form4.xml · nonDerivative · entry 1 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610.3653 Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 12:14 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
SaleCommon Stock | 3,280 | $181.50 | $595,316.39 |
DisclosureSEC source: 0001127602-18-019467 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,563 F2 · price: The price of $181.4989 per share represents a weighted average of sales prices ranging from $181.29 to $181.87 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 30, 2018 Filed Jun 1, 2018 12:14 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
SaleCommon Stock | 6,720 | $181.06 | $1,216,748.74 |
DisclosureSEC source: 0001127602-18-019467 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,843 F1 · price: The price of $181.0638 per share represents a weighted average of sales prices ranging from $180.29 to $181.28 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 23, 2018 Filed May 25, 2018 15:15 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionNon-qualified Stock Options · Derivative | 49,966 | $0.00 Strike: $84.86 | $0.00 |
DisclosureSEC source: 0001127602-18-018931 · form4.xml · derivative · entry 6 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 49,966 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable. Read SEC document |
| May 23, 2018 Filed May 25, 2018 15:15 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 5,400 | $176.13 | $951,091.74 |
DisclosureSEC source: 0001127602-18-018931 · form4.xml · nonDerivative · entry 3 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,669.3298 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price of $176.1281 per share represents a weighted average of sales prices ranging from $176.01 to $176.54 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 23, 2018 Filed May 25, 2018 15:15 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 44,566 | $175.27 | $7,811,252.17 |
DisclosureSEC source: 0001127602-18-018931 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 227,069.3298 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price of $175.2738 per share represents a weighted average of sales prices ranging from $175.00 to $175.998 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| May 23, 2018 Filed May 25, 2018 15:15 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 49,966 | $84.86 | $4,240,114.76 |
DisclosureSEC source: 0001127602-18-018931 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,635.3298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 20:59 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionNon-qualified Stock Options · Derivative | 49,967 | $0.00 Strike: $84.86 | $0.00 |
DisclosureSEC source: 0001127602-18-015249 · form4.xml · derivative · entry 6 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,966 Underlying: Common Stock · 49,967 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F5 · derivative.exercise_date: The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 20:59 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 21,200 | $166.37 | $3,526,984.64 |
DisclosureSEC source: 0001127602-18-015249 · form4.xml · nonDerivative · entry 3 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,669.3298 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price of $166.3672 per share represents a weighted average of sales prices ranging from $166.23 to $166.67 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 20:59 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 28,767 | $165.94 | $4,773,711.05 |
DisclosureSEC source: 0001127602-18-015249 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,869.3298 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price of $165.9440 per share represents a weighted average of sales prices ranging from $165.23 to $166.225 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| April 23, 2018 Filed Apr 25, 2018 20:59 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 49,967 | $84.86 | $4,240,199.62 |
DisclosureSEC source: 0001127602-18-015249 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,636.3298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| April 04, 2018 Filed Apr 6, 2018 13:39 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014200 · form4.xml · derivative · entry 3 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,221 Underlying: Common Stock · 3,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 4/4/18. F3 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 4/4/18. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| April 04, 2018 Filed Apr 6, 2018 13:39 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Tax withholdingCommon Stock | 1,376 | $163.84 | $225,443.84 |
DisclosureSEC source: 0001127602-18-014200 · form4.xml · nonDerivative · entry 2 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,220.3653 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| April 04, 2018 Filed Apr 6, 2018 13:39 UTC |
Gary M. HuffCEO, LabCorp Diagnostics
|
Exercise / conversionCommon Stock | 3,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-014200 · form4.xml · nonDerivative · entry 1 Gary M. Huff · CIK 0001702387 · CEO, LabCorp Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,596.3653 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| April 03, 2018 Filed Apr 5, 2018 14:14 UTC |
Ratliff John DCEO, Covance Drug Development
|
GrantRestricted Stock Unit · Derivative | 12,120 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-014165 · form4.xml · derivative · entry 1 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,337 Underlying: Common Stock · 12,120 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units will vest in three installments as follows: 20% of the Restricted Stock Units will vest on April 3, 2019; 30% of the Restricted Stock Units will vest on April 3, 2020; and 50% of the Restricted Stock Units will vest on April 3, 2021. F2 · derivative.expiration_date: The Restricted Stock Units will vest in three installments as follows: 20% of the Restricted Stock Units will vest on April 3, 2019; 30% of the Restricted Stock Units will vest on April 3, 2020; and 50% of the Restricted Stock Units will vest on April 3, 2021. F3 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:54 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 2,121 | $161.75 | $343,071.75 |
DisclosureSEC source: 0001127602-18-013183 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,440 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:54 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
GrantCommon Stock | 4,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013183 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,561 F1 · kind: Shares acquired on March 29, 2018, pursuant to a performance award granted on March 11, 2015, relating to performance during the three-year period ended December 31, 2017. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:53 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 1,600 | $161.75 | $258,800.00 |
DisclosureSEC source: 0001127602-18-013182 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,112.9891 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:53 UTC |
Dodson Edward TPrincipal Accounting Officer
|
GrantCommon Stock | 4,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013182 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,712.9891 F1 · kind: Shares acquired on March 29, 2018, pursuant to a performance award granted on March 11, 2015, relating to performance during the three-year period ended December 31, 2017. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:51 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Tax withholdingCommon Stock | 2,152 | $161.75 | $348,086.00 |
DisclosureSEC source: 0001127602-18-013181 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,062 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:51 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
GrantCommon Stock | 5,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013181 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,214 F1 · kind: Shares acquired on March 29, 2018, pursuant to a performance award granted on March 11, 2015, relating to performance during the three-year period ended December 31, 2017. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:50 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
Tax withholdingCommon Stock | 8,850 | $161.75 | $1,431,487.50 |
DisclosureSEC source: 0001127602-18-013180 · form4.xml · nonDerivative · entry 2 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,563 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:50 UTC |
EISENBERG GLENN AChief Financial Officer, EVP
|
GrantCommon Stock | 19,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013180 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Chief Financial Officer, EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,413 F1 · kind: Shares acquired on March 29, 2018, pursuant to a performance award granted on March 11, 2015, relating to performance during the three-year period ended December 31, 2017. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:48 UTC |
KING DAVID PDirector · President & CEO
|
Tax withholdingCommon Stock | 33,015 | $161.75 | $5,340,176.25 |
DisclosureSEC source: 0001127602-18-013179 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,669.3298 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:48 UTC |
KING DAVID PDirector · President & CEO
|
GrantCommon Stock | 73,449 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013179 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,684.3298 F1 · kind: Shares acquired on March 29, 2018, pursuant to a performance award granted on March 11, 2015, relating to performance during the three-year period ended December 31, 2017. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:47 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Tax withholdingCommon Stock | 2,828 | $161.75 | $457,429.00 |
DisclosureSEC source: 0001127602-18-013178 · form4.xml · nonDerivative · entry 2 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,254.6826 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| March 29, 2018 Filed Apr 2, 2018 15:47 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
GrantCommon Stock | 6,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-013178 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,082.6826 F1 · kind: Shares acquired on March 29, 2018, pursuant to a performance award granted on March 11, 2015, relating to performance during the three-year period ended December 31, 2017. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 13:03 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionNon-qualified Stock Options · Derivative | 49,967 | $0.00 Strike: $84.86 | $0.00 |
DisclosureSEC source: 0001127602-18-012824 · form4.xml · derivative · entry 8 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,933 Underlying: Common Stock · 49,967 shares Expires 2022-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F7 · derivative.exercise_date: The option vested in three equal annual installments beginning on 05/24/2013 and is now fully exercisable. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 13:03 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 1,700 | $166.38 | $282,837.84 |
DisclosureSEC source: 0001127602-18-012824 · form4.xml · nonDerivative · entry 5 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,235.3298 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F5 · price: The price of $166.3752 per share represents a weighted average of sales prices ranging from $166.089 to $166.80 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 13:03 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 10,313 | $165.39 | $1,705,657.79 |
DisclosureSEC source: 0001127602-18-012824 · form4.xml · nonDerivative · entry 4 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,935.3298 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F4 · price: The price of $165.3891 per share represents a weighted average of sales prices ranging from $164.99 to $165.94 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 13:03 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 36,265 | $164.55 | $5,967,434.76 |
DisclosureSEC source: 0001127602-18-012824 · form4.xml · nonDerivative · entry 3 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,248.3298 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F3 · price: The price of $164.5508 per share represents a weighted average of sales prices ranging from $163.995 to $164.98 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 13:03 UTC |
KING DAVID PDirector · President & CEO
|
SaleCommon Stock | 1,689 | $163.58 | $276,287.46 |
DisclosureSEC source: 0001127602-18-012824 · form4.xml · nonDerivative · entry 2 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 229,513.3298 F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. F2 · price: The price of $163.5805 per share represents a weighted average of sales prices ranging from $162.96 to $163.865 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 23, 2018 Filed Mar 27, 2018 13:03 UTC |
KING DAVID PDirector · President & CEO
|
Exercise / conversionCommon Stock | 49,967 | $84.86 | $4,240,199.62 |
DisclosureSEC source: 0001127602-18-012824 · form4.xml · nonDerivative · entry 1 KING DAVID P · CIK 0001275654 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,202.3298 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:12 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-011543 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,534 Underlying: Common Stock · 400 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 3/11/2016 and are now fully vested. F4 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 3/11/2016 and are now fully vested. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| March 12, 2018 Filed Mar 14, 2018 20:12 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 111 | $175.61 | $19,492.71 |
DisclosureSEC source: 0001127602-18-011543 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,860.9891 F3 · kind: Stock withholding to satisfy tax withholding obligations. F2 · balance_after: Amount includes 24 and 42 shares that were inadvertently omitted from the reporting person's original Forms 4 filed on April 9, 2018 and April 13, 2018, respectively, due to a clerical error. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.